167 related articles for article (PubMed ID: 8556950)
21. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
22. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
[TBL] [Abstract][Full Text] [Related]
23. The value of proliferating cell nuclear antigen (PCNA)/cyclin in the assessment of cell proliferation in glomerulonephritis.
Nakopoulou L; Stefanaki K; Salpigidis K; Boletis J; Papadakis J; Zeiss PM; Vosnides G
Histol Histopathol; 1997 Jul; 12(3):655-62. PubMed ID: 9225147
[TBL] [Abstract][Full Text] [Related]
24. Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures.
Bustamante AS; Guervós MA; de los Toyos JR; Dolbeare F; Sampedro A
Anal Cell Pathol; 1996 Jul; 11(2):127-36. PubMed ID: 8844110
[TBL] [Abstract][Full Text] [Related]
25. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
26. Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer.
Kovac D; Rubinic M; Krasevic M; Krizanac S; Petrovecki M; Stimac D; Melato M
Anticancer Res; 1995; 15(5B):2301-2. PubMed ID: 8572642
[TBL] [Abstract][Full Text] [Related]
27. A novel immunohistochemical method to estimate cell-cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer.
Scott IS; Morris LS; Bird K; Davies RJ; Vowler SL; Rushbrook SM; Marshall AE; Laskey RA; Miller R; Arends MJ; Coleman N
J Pathol; 2003 Oct; 201(2):187-97. PubMed ID: 14517835
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci.
Miura M; Watanabe H; Sasaki T; Tatsumi K; Muto M
Exp Cell Res; 2001 Feb; 263(2):202-8. PubMed ID: 11161719
[TBL] [Abstract][Full Text] [Related]
29. Regulation of cell cycle and apoptosis by protein kinase C in rat myeloid leukemia cell line.
Leszczynski D
Oncol Res; 1995; 7(9):471-80. PubMed ID: 8835291
[TBL] [Abstract][Full Text] [Related]
30. Analysis of key cell-cycle checkpoint proteins in colorectal tumours.
McKay JA; Douglas JJ; Ross VG; Curran S; Loane JF; Ahmed FY; Cassidy J; McLeod HL; Murray GI
J Pathol; 2002 Apr; 196(4):386-93. PubMed ID: 11920733
[TBL] [Abstract][Full Text] [Related]
31. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
34. [In vitro experiment of inhibiting cell proliferation on human esophageal squamous cell cancer T. Tn cell line by proliferating cell nuclear antigen antisense oligodeoxynucleotide].
Yang L; Ye SD; Feng LG; Wang JS; Zhai W
Ai Zheng; 2002 Mar; 21(3):276-80. PubMed ID: 12451994
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of lens epithelial cell cycle and PCNA mRNA expression by an antisense oligonucleotides complementary to the messenger RNA of proliferating cell nuclear antigen].
Weng JN; Zhang HR
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):98-101. PubMed ID: 12783689
[TBL] [Abstract][Full Text] [Related]
36. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
37. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
38. Two cell-cycle regulated SET-domain proteins interact with proliferating cell nuclear antigen (PCNA) in Arabidopsis.
Raynaud C; Sozzani R; Glab N; Domenichini S; Perennes C; Cella R; Kondorosi E; Bergounioux C
Plant J; 2006 Aug; 47(3):395-407. PubMed ID: 16771839
[TBL] [Abstract][Full Text] [Related]
39. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis.
Delhaye M; Louis H; Degraef C; Le Moine O; Devière J; Gulbis B; Jacobovitz D; Adler M; Galand P
Hepatology; 1996 May; 23(5):1003-11. PubMed ID: 8621125
[TBL] [Abstract][Full Text] [Related]
40. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
